PJP / PJP: Concentrating On Large-Cap Biopharmaceuticals Seems To Be A Bad Strategy

A smart beta exchange traded fund, the Invesco Pharmaceuticals ETF (PJP) debuted on 06/23/2005, and offers broad exposure to the Health Care ETFs cate more_horizontal

Healthcare, the second-largest sector allocation in the S&P 500, is often viewed through the lens of defensive and value traits. The latter scenario i more_horizontal

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively manag more_horizontal

President Joe Biden on Tuesday pledged to “keep standing up to Big Pharma,” as he celebrated his administration's rollout of the first 10 drugs to more_horizontal

It has been almost a month since the second-quarter earnings season kicked off. These sectors emerged winners so far in this earnings season. more_horizontal

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Dynamic Pharmaceutica more_horizontal

55 percent of Invesco Dynamic Pharmaceuticals ETF's investment is in ten giant-capitalized and large-capitalized biopharmaceutical stocks which delive more_horizontal

Launched on 06/23/2005, the Invesco Dynamic Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure more_horizontal